Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields.
Research
RF Safe Research Library
Jan 1, 2025
This study reports that glioblastoma-specific amplitude-modulated 27.12 MHz RF electromagnetic fields (delivered intrabuccally) inhibited proliferation in several glioblastoma cell lines exposed 3 hours/day at patient-matched levels. The authors propose a mechanism involving CACNA1H and modulation of the “Mitotic…